| 1. |
Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention[J]. Arthritis Rheum, 1998, 41(8): 1343-1355.
|
| 2. |
徐苓, Michael CN, Zhang YQ, et al. 北京城区老年人膝、髋和手骨关节炎的患病率及其与美国白人患病率的比较研究[J]. 中华医学杂志, 2003, 83(14): 1206-1209.
|
| 3. |
Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis[J]. Cochrane Database Syst Rev, 2006(1): CD004257.
|
| 4. |
Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs[J]. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-S30.
|
| 5. |
Hochberg MC, Altman RD, April KT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee[J]. Arthritis Care Res (Hoboken), 2012, 64(4): 465-474.
|
| 6. |
Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs[J]. JAMA, 1999, 282(20): 1929-1933.
|
| 7. |
Anon. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines[J]. Arthritis Rheum, 2000, 43(9): 1905-1915.
|
| 8. |
Anon. The management of chronic pain in older persons: AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society[J]. J Am Geriatr Soc, 1998, 46(5): 635-651.
|
| 9. |
Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials[J]. J Rheumatol, 2006, 33(9): 1841-1844.
|
| 10. |
Lin J, Zhang W, Jones A, et al. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials[J]. BMJ, 2004, 329(7461): 324.
|
| 11. |
Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis[J]. Eur J Clin Pharmacol, 1994, 46(6): 517-522.
|
| 12. |
Pelletier JP, Martel-Pelletier J. Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology[J]. Ann Rheum Dis, 2003, 62(Suppl 2): ii79-ii82.
|
| 13. |
Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis[J]. Arch Intern Med, 2003, 163(13): 1514-1522.
|
| 14. |
Durmus D, Alayli G, Aliyazicioglu Y, et al. Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial[J/OL]. Rheumatol Int, 2012. [2012-11-01]. http://link.springer.com/content/pdf/10.1007%2Fs00296-012-2401-9.
|
| 15. |
Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials[J]. Osteoarthritis Cartilage, 2008, 16(2): 254-260.
|
| 16. |
Mcalindon TE, Lavalley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis[J]. JAMA, 2000, 283(11): 1469-1475.
|
| 17. |
Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee[J]. Cochrane Database Syst Rev, 2006(2): CD005328.
|
| 18. |
Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage[J]. Arthritis Rheum, 2005, 52(1): 128-135.
|
| 19. |
Pelletier JP, Dibattista JA, Roughley P, et al. Cytokines and inflammation in cartilage degradation[J]. Rheum Dis Clin North Am, 1993, 19(3): 545-568.
|
| 20. |
Martel-Pelletier J, Mineau F, Jolicoeur FC, et al. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes[J]. J Rheumatol, 1998, 25(4): 753-762.
|
| 21. |
Felisaz N, Boumediene K, Ghayor C, et al. Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1[J]. Osteoarthritis Cartilage, 1999, 7(3): 255-264.
|
| 22. |
Rintelen B, Neumann K, Leeb BF. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis[J]. Arch Intern Med, 2006, 166(17): 1899-1906.
|
| 23. |
Schnitzer TJ. New pharmacologic approaches in the management of osteoarthritis[J]. Arthritis Care Res (Hoboken), 2010, 62(8): 1174-1180.
|
| 24. |
Karsdal MA, Byrjalsen I, Henriksen K, et al. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study[J]. Osteoarthritis Cartilage, 2010, 18(2): 150-159.
|
| 25. |
Wan R, Hu J, Zhou Q, et al. Application of co-expressed genes to articular cartilage: new hope for the treatment of osteoarthritis (review)[J]. Mol Med Report, 2012, 6(1): 16-18.
|
| 26. |
Intema F, Van Roermund PM, Marijnissen AC, et al. Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study[J]. Ann Rheum Dis, 2011, 70(8): 1441-1446.
|
| 27. |
Zaffagnini S, Marcheggiani Muccioli GM, Lopomo N, et al. Prospective long-term outcomes of the medial collagen meniscus implant versus partial medial meniscectomy: a minimum 10-year follow-up study[J]. Am J Sports Med, 2011, 39(5): 977-985.
|
1/5
WeChat